Nicotinamide inhibits melanoma in vitro and in vivo

BACKGROUND: Even though new therapies are available against melanoma, novel approaches are needed to overcome resistance and high-toxicity issues. In the present study the anti-melanoma activity of Nicotinamide (NAM), the amide form of Niacin, was assessed in vitro and in vivo. METHODS: Human (A375,...

Descripción completa

Detalles Bibliográficos
Autores principales: Scatozza, Francesca, Moschella, Federica, D’Arcangelo, Daniela, Rossi, Stefania, Tabolacci, Claudio, Giampietri, Claudia, Proietti, Enrico, Facchiano, Francesco, Facchiano, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542872/
https://www.ncbi.nlm.nih.gov/pubmed/33028392
http://dx.doi.org/10.1186/s13046-020-01719-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542872/
https://www.ncbi.nlm.nih.gov/pubmed/33028392
http://dx.doi.org/10.1186/s13046-020-01719-3

Ejemplares similares